# Antonino Petralia

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/antonino-petralia/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,015 |
| Field | Schizophrenia research and treatment |
| h-index | 16 |
| i10-index | 21 |
| Last Known Institution | University of Catania |
| OpenAlex ID | https://openalex.org/A5102726643 |
| Works | 70 |

## Researcher papers

- [Curcumin for depression: a meta-analysis](https://scholariq.org/papers/curcumin-for-depression-a-meta-analysis/)
- [Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases](https://scholariq.org/papers/heat-shock-proteins-and-hormesis-in-the-diagnosis-and-treatment-of/)
- [Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial](https://scholariq.org/papers/efficacy-of-pregabalin-and-venlafaxine-xr-in-generalized-anxiety-disorder/)
- [Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies](https://scholariq.org/papers/cannabinoids-for-people-with-asd-a-systematic-review-of-published-and-ongoing/)
- [Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer](https://scholariq.org/papers/multicentre-randomised-phase-iii-study-comparing-the-same-dose-and-schedule-of/)
- [Is It Time for a Paradigm Shift in the Treatment of Schizophrenia? The Use of Inflammation-Reducing and Neuroprotective Drugs—A Review](https://scholariq.org/papers/is-it-time-for-a-paradigm-shift-in-the-treatment-of-schizophrenia-the-use-of/)
- [Analytical approaches to the diagnosis and treatment of aging and aging-related disease: redox status and proteomics](https://scholariq.org/papers/analytical-approaches-to-the-diagnosis-and-treatment-of-aging-and-aging-related/)
- [Self-Reported Autistic Traits Using the AQ: A Comparison between Individuals with ASD, Psychosis, and Non-Clinical Controls](https://scholariq.org/papers/self-reported-autistic-traits-using-the-aq-a-comparison-between-individuals-with/)
- [Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer](https://scholariq.org/papers/multicenter-randomized-clinical-trial-on-high-dose-epirubicin-plus-cis-platinum/)
- [Paliperidone palmitate in non-acute patients with schizophrenia previously unsuccessfully treated with risperidone long-acting therapy or frequently used conventional depot antipsychotics](https://scholariq.org/papers/paliperidone-palmitate-in-non-acute-patients-with-schizophrenia-previously/)

## Researcher topics

- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Tryptophan and brain disorders](https://scholariq.org/topics/tryptophan-and-brain-disorders/)
- [Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes](https://scholariq.org/topics/anxiety-depression-psychometrics-treatment-cognitive-processes/)
- [Treatment of Major Depression](https://scholariq.org/topics/treatment-of-major-depression/)
- [Autism Spectrum Disorder Research](https://scholariq.org/topics/autism-spectrum-disorder-research/)

## Researcher university

- [University of Catania](https://scholariq.org/institutions/university-of-catania/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.